GE Aerospace vs UnitedHealth Group Inc — how do they compare? GE Aerospace trades at $308.2 (market cap $317.10B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: GE Aerospace and UnitedHealth Group Inc are close in size by market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold GE Aerospace for 111 Days and UnitedHealth Group Inc for 97 Days on average.
| GE | UNH | |
|---|---|---|
Market Cap | $317.10B | $332.96B |
Volume | 6,320,106 | 7,273,749 |
Sector | Industrials | Health |
52-Week High | $381.22 | $436.35 |
52-Week Low | $273.25 | $259.02 |
Typical Hold Time | 111 Days | 97 Days |
Enterprise Value | $326.91B | $374.82B |
Dividend Yield | 0.62% | 2.5% |
Signals from Pluang's Aura AI — not financial advice
GE Aerospace (GE) trades at $305.62, up 0.66% on the day, but faces a near-term bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.02 exceeding the $1.86 estimate. Revenue growth is accelerating, reaching $45.86 billion in 2025, while net income margins improved to 17.72%. However, the stock's high valuation multiples, including a P/E of 36.04, and a significant $12 billion acquisition of Consolidated Precision Products, present both opportunity and scrutiny.
The outlook remains positive driven by strong defense demand and shareholder returns, including a $20 billion buyback and raised dividend. Analyst consensus is strongly bullish with a $409.60 price target, though risks include integration challenges from the CPP deal, cost pressures, and high debt levels. The stock's current price is approximately 25% below the consensus target, suggesting potential upside if execution risks are managed.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →